Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Trial Structure Duration: 48 weeks of treatment Participants: 338 adults randomized 2:1:1:1:1:2:2 to placebo or retatrutide groups Doses tested: 1mg, 4mg, 8mg, 12mg (all with slow titration from 2mg starting dose) Lifestyle intervention: All participants received counseling on diet (500 kcal/day deficit) and exercise (150 min/week) Primary endpoint: Percent weight change at 24 weeks Key secondary endpoints: Weight change at 48 weeks, proportion achieving 5%, 10%, 15% loss The trial used a slow titration protocol to minimize side effects: all groups except the 1mg dose started at 2mg weekly and escalated every 4 weeks
The assessment criteria for this training program include both observation and a written assessment
10.1007/s10529-010-0364-z Biotechnol
Arvat E, Di Vito L, Broglio F, et al
This ensures that every treatment approach is tailored, effective, and safe for long-term health benefits
Universities, federal agencies, and pharmaceutical companies are investing significant resources to determine whether drugs like semaglutide could become a legitimate tool in addiction medicine
US$ 24.40
US$ 22.43
US$ 28.17
US$ 28.98
US$ 20.34
US$ 28.79
